Drugs / PHEN/TPM ER
PHEN/TPM ER
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02659475 | Sep 2015 → Jul 2016 | binge eating disorder | Lindner Center of HOPE | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PHEN/TPM ER | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02659475 ↗ |
| Known as | phentermine-topiramate | “the combination of phentermine and topiramate extended release (phentermine-topiramate)” PMID 30013815 ↗ Jun 2018 |
| Known as | Qsymia | “PHEN/TPM ER (Qsymia®)” NCT02659475 ↗ |